A detailed history of Parkman Healthcare Partners LLC transactions in Mannkind Corp stock. As of the latest transaction made, Parkman Healthcare Partners LLC holds 3,304,085 shares of MNKD stock, worth $22.3 Million. This represents 2.93% of its overall portfolio holdings.

Number of Shares
3,304,085
Previous 2,409,599 37.12%
Holding current value
$22.3 Million
Previous $12.6 Million 64.96%
% of portfolio
2.93%
Previous 1.86%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.01 - $6.7 $4.48 Million - $5.99 Million
894,486 Added 37.12%
3,304,085 $20.7 Million
Q2 2024

Aug 14, 2024

BUY
$4.05 - $5.43 $14,835 - $19,890
3,663 Added 0.15%
2,409,599 $12.6 Million
Q1 2024

May 15, 2024

SELL
$3.25 - $5.27 $301,236 - $488,465
-92,688 Reduced 3.71%
2,405,936 $10.9 Million
Q4 2023

Feb 14, 2024

BUY
$3.34 - $4.29 $1.44 Million - $1.84 Million
429,677 Added 20.77%
2,498,624 $9.09 Million
Q3 2023

Nov 14, 2023

BUY
$3.91 - $5.45 $986,751 - $1.38 Million
252,366 Added 13.89%
2,068,947 $8.54 Million
Q2 2023

Aug 11, 2023

BUY
$3.72 - $4.79 $1.27 Million - $1.64 Million
342,483 Added 23.23%
1,816,581 $7.39 Million
Q1 2023

May 12, 2023

BUY
$3.95 - $5.63 $1.75 Million - $2.49 Million
442,989 Added 42.96%
1,474,098 $6.04 Million
Q4 2022

Feb 13, 2023

BUY
$3.02 - $5.37 $320,512 - $569,918
106,130 Added 11.47%
1,031,109 $5.43 Million
Q3 2022

Nov 14, 2022

BUY
$2.99 - $4.35 $478,893 - $696,717
160,165 Added 20.94%
924,979 $2.86 Million
Q2 2022

Aug 12, 2022

BUY
$2.67 - $4.77 $238,727 - $426,490
89,411 Added 13.24%
764,814 $2.91 Million
Q1 2022

May 13, 2022

BUY
$2.62 - $4.45 $1.07 Million - $1.82 Million
409,548 Added 154.05%
675,403 $2.49 Million
Q4 2021

Feb 11, 2022

BUY
$4.05 - $5.37 $43,772 - $58,038
10,808 Added 4.24%
265,855 $1.16 Million
Q3 2021

Nov 12, 2021

SELL
$3.89 - $5.48 $2.14 Million - $3.01 Million
-550,000 Reduced 68.32%
255,047 $1.11 Million
Q2 2021

Aug 13, 2021

BUY
$3.61 - $5.45 $1.46 Million - $2.21 Million
405,047 Added 101.26%
805,047 $4.39 Million
Q1 2021

May 14, 2021

BUY
$3.14 - $6.14 $1.26 Million - $2.46 Million
400,000 New
400,000 $1.57 Million
Q4 2020

Feb 12, 2021

SELL
$1.79 - $4.04 $628,701 - $1.42 Million
-351,230 Closed
0 $0
Q3 2020

Nov 13, 2020

SELL
$1.56 - $2.08 $311,823 - $415,764
-199,887 Reduced 36.27%
351,230 $660,000
Q2 2020

Aug 13, 2020

SELL
$0.94 - $2.21 $329,000 - $773,500
-350,000 Reduced 38.84%
551,117 $964,000
Q1 2020

May 15, 2020

SELL
$0.84 - $1.76 $440,315 - $922,565
-524,185 Reduced 36.78%
901,117 $928,000
Q4 2019

Feb 13, 2020

BUY
$1.14 - $1.49 $1.62 Million - $2.12 Million
1,425,302 New
1,425,302 $1.84 Million

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.73B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Parkman Healthcare Partners LLC Portfolio

Follow Parkman Healthcare Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parkman Healthcare Partners LLC with notifications on news.